Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
10. November 2025
Search
medline.ch
Urology-Nephrology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 22789
Articles 1 - 20 / 455775
Perioperative Acute Kidney Injury: What's New in 2025?
J Cardiothorac Vasc Anesth
Elmadhoun O, Ramanujan K, Wieruszewski PM, Almadhoun H, Arboleda AL, Munoz-Acuna R, Cheungpasitporn W, Yalamuri SM, Ramakrishna H.
PMID: 41207837 [PubMed - as supplied by publisher]
Neoadjuvant Antiandrogen Therapy With or Without MEK or SRC Inhibition for Unfavorable-risk Prostate Cancer: A Phase 2 Randomized Clinical Trial.
Eur Urol Oncol
Agrawal R, Weiner AB, Livingstone J, Pooli A, Huang RR, Ye H, Sisk A, Elashoff DA, Boutros PC, Rettig MB, Reiter RE.
PMID: 41207813 [PubMed - as supplied by publisher]
REMODELing Mechanistic Trials for Kidney Disease: a multi-modal, tissue-centered approach to understand the renal mechanism of action of semaglutide.
Kidney Int
Pruijm M, Belmar N, Bjornstad P, Cherney DZI, Das V, Gunnarsson T, Hodgin JB, Schytz PA, Tuttle KR, Kretzler M.
PMID: 41207620 [PubMed - as supplied by publisher]
GLP-1RAs and tirzepatide may reduce heart failure risk in obese but not in non-obese patients with cardiovascular or renal disease: A systematic review and meta-analysis.
Metabolism
Zhang J, Guan X, Kong M, Xia M, Yu Y, Zhang C.
PMID: 41207615 [PubMed - as supplied by publisher]
Risk of deficient mismatch repair colorectal cancer and precursors after kidney transplantation: a nationwide study.
Am J Transplant
Zwart K, van Kruijsdijk RCM, Angerilli V, Baas MC, Dekker E, Rutgers N, May A, Koopman M, Nagtegaal ID, Bol GM.
PMID: 41207478 [PubMed - as supplied by publisher]
Precision mapping of hybrid schistosomes in urogenital schistosomiasis: Research lessons learned from stakeholder dialogue, community engagement and household access in two study communities in southern Malawi.
Acta Trop
Namacha G, Makaula P, Kapira DR, Lally D, Chammudzi P, Ntaba BP, Mainga B, O'Ferrall AM, Jones S, Archer J, Juhász A, Cunningham L, Chipeta M, Falijalla A, Chilumbu S, Minyaliwa F, Luhanga M, Kayuni SA, Stothard JR, Musaya J.
PMID: 41207413 [PubMed - as supplied by publisher]
All-Cause Mortality and Bleeding Risks Associated With Serotonin Reuptake Inhibitors in Patients With End-Stage Kidney Disease and Depression: A Nationwide Cohort Study.
Psychiatry Investig
Lee J, Park M, Shin DH, Park S, Jung YS, Park K, Cambridge CK, Park S, Han BG, Lee JY.
PMID: 41207278 [PubMed - in process]
The role of genital hiatus and perineal body lengths in diagnosing stress and urge urinary incontinence.
Eur J Obstet Gynecol Reprod Biol
Kubra B, Nura Fitnat TS, Huseyin K.
PMID: 41207072 [PubMed - as supplied by publisher]
Impact of gender-affirming hormone therapy on spermatogenesis: analysis of testicular histological specimens.
Hum Reprod
Wilk Goldsher Y, Al-Hadi H, Mullen B, Potter E, MacLeod E, Lajkosz K, Karavani G, Krakowsky Y, Grober ED, Millman AL.
PMID: 41206903 [PubMed - as supplied by publisher]
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection.
Diabetologia
Jansz TT, Young KG, Hopkins R, McGovern AP, Shields BM, Hattersley AT, Jones AG, Pearson ER, Bingham C, Oram RA, Dennis JM, MASTERMIND Consortium.
PMID: 41206830 [PubMed - as supplied by publisher]
Sodium-glucose co-transporter 2 inhibitors in severe estimated glomerular filtration rate deterioration across cardiovascular-kidney- metabolic conditions: A pooled analysis of randomized trials.
Eur J Heart Fail
Ferreira JP, Marques P, Anker SD, Butler J, Filippatos G, Sharma A, Vasques-Nóvoa F, Mendonça L, Neves JS, Packer M, Zannad F.
PMID: 41206806 [PubMed - as supplied by publisher]
Serum uric acid-creatinine ratio as a marker of chronic kidney disease: a retrospective observational study.
Biomark Med
Karaduru Avc, , Sarg, Turgut B, R, Gül S, Y.
PMID: 41206782 [PubMed - as supplied by publisher]
Myalgia as Initial Presentation of Microscopic Polyangiitis: Diagnostic Utility of Kidney Biopsy.
Mod Rheumatol Case Rep
Wakatsuki M, Oba Y, Kanda-Kikuchi J, Kono K, Yamanouchi M, Suwabe T, Ubara Y, Sugimoto I, Ohashi K, Sawa N.
PMID: 41206717 [PubMed - as supplied by publisher]
Lifetime occupational and para-occupational exposure to organic solvents and testicular germ cell tumor risk: a French case-control study-TESTIS.
Int J Epidemiol
Guth M, Lefevre M, Coste A, Praud D, Perol O, Pilorget C, Dananché B, Danjou A, Perrin J, Drouineaud V, Bujan L, Schüz J, Olsson A, Charbotel B, Fervers B, TESTIS Study Group.
PMID: 41206641 [PubMed - in process]
To stop or not to stop. Endoscopic enucleation of the prostate in patients on blood thinners: outcomes, a real-life prospective multicenter study of 932 cases.
World J Urol
Castellani D, Yuen SK, Giulioni C, Fong KY, Doizi S, Moretto S, Zawadzki M, Tanidir Y, Gökce MI, Mahajan A, Sytnik D, Alkandari A, Becker B, Aydin C, Akdogan N, Bulut EC, More S, De Coninck V, Xu A, Gadzhiev N, Malkhasyan V, Tan K, Lim YW, Laymon MNI, Mazzon G, Sarvajit BP, Chiruvella M, Enikeev D, Somani B, AbdelAziz O, Herrmann T, Gauhar V.
PMID: 41206372 [PubMed - in process]
Five-year Outcomes for Men after Negative Magnetic Resonance Imaging (MRI) or Negative Biopsy in the RAPID MRI-directed Prostate Cancer Diagnostic Pathway.
Eur Urol
Ng CPY, Light A, Eragamreddy SK, Boaz RJ, Hunter A, Ashour O, Alderton D, Nicholls L, Hug O, Ang JZ, Raja A, Chua C, Hasan H, Wong F, Matthews M, Bhola-Stewart H, Adzawoloo-Andersson I, Mendoza R, Smith A, Lloyd J, Yeung M, Silvanto A, Mannion E, Lakhani A, Rockall A, Clark M, Tam H, Tanaka MB, Winkler M, Ahmed HU, Shah TT.
PMID: 41206290 [PubMed - as supplied by publisher]
Radiotherapy plus Long-term Adjuvant Androgen Deprivation with a Luteinizing Hormone-releasing Hormone Antagonist Versus Agonist in Patients with Very High-risk Localized or Locally Advanced Prostate Cancer: The EORTC GUCG-1414 Phase 3 Randomized Trial.
Eur Urol Oncol
Zilli T, Böhmer D, Roeder A, Lauffer D, Villafranca Iturre AE, Jové-Teixidó JJ, Supiot S, Latorzeff I, Dirix P, Otte FX, Francolini G, Roumeguère T, Simon JM, Fournier B, Fortpied C, Lara PC, Tombal B.
PMID: 41206286 [PubMed - as supplied by publisher]
Practice variations in pharmacological management of acute renal colic pain: A cross-sectional survey study.
Australas Emerg Care
Lee N, McCarthy A, Ballard E, Eley R, Isoardi K, Hughes J.
PMID: 41206284 [PubMed - as supplied by publisher]
PSA response to predict progression in metastatic hormone-sensitive prostate cancer (mHSPC) patients. When is the optimal time point?
Urol Oncol
Martínez-Corral R, Pérez-Fentes D, Bardella-Altarriba C, Vera-Ballesteros FJ, Abella-Serra A, Antón Fuente S, Martínez-Corral ME, Picola-Brau N, López-Abad A, Gómez-Ferrer Á, Beamud-Cortés M, Suárez-Novo JF, López-González PA, García-Puche M, Álvarez-Gracia AM, De Pablos-Rodríguez P.
PMID: 41206248 [PubMed - as supplied by publisher]
Evaluation of the utility of molecular subtype classification by immunohistochemistry in bladder cancer undergoing radical cystectomy: a retrospective cohort study.
Jpn J Clin Oncol
Ikehata Y, Nishiyama N, Ishida S, Kitamura H.
PMID: 41206094 [PubMed - as supplied by publisher]
Articles 1 - 20 / 455775
Page 1 of 22789
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy